Cristina Larkin serves as Executive at Spero Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Cristina Larkin has executed 7 insider transactions totaling $319.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 1, 2022 involved receiving (via award) 38,014 shares valued at $0.
Cristina Larkin currently holds 63,581 shares of Spero Therapeutics, Inc. (SPRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cristina Larkin has been a net seller of SPRO stock. They have purchased $21.0K and sold $298.0K worth of shares.
Cristina Larkin's most recent insider trade was on Feb 1, 2022, when they sold 38,014 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 16, 2020 | SPRO | $228.0K | Sale | 12,000 | $19.00 | Discretionary |
| Dec 16, 2020 | SPRO | $70.8K | Option Exercise | 12,000 | $5.90 | Discretionary |
| Jul 5, 2018 | SPRO | $70.0K | Sale | 4,000 | $17.50 | Discretionary |
| Jul 5, 2018 | SPRO | $23.6K | Option Exercise | 4,000 | $5.90 | Discretionary |
| Nov 6, 2017 | SPRO | $21.0K | Purchase | 1,500 | $14.00 | Discretionary |